Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis.

Homma Y, Nomiya A, Tagaya M, Oyama T, Takagaki K, Nishimatsu H, Igawa Y.

J Urol. 2013 Nov;190(5):1925-31. doi: 10.1016/j.juro.2013.05.049. Epub 2013 May 28.

PMID:
23727186
2.

Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis.

Zeng Y, Wu XX, Homma Y, Yoshimura N, Iwaki H, Kageyama S, Yoshiki T, Kakehi Y.

J Urol. 2007 Oct;178(4 Pt 1):1322-7; discussion 1327. Epub 2007 Aug 14.

PMID:
17698128
3.

CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis.

Ogawa T, Homma T, Igawa Y, Seki S, Ishizuka O, Imamura T, Akahane S, Homma Y, Nishizawa O.

J Urol. 2010 Mar;183(3):1206-12. doi: 10.1016/j.juro.2009.11.007. Epub 2010 Jan 22.

PMID:
20096889
4.

Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome.

Liu BL, Yang F, Zhan HL, Feng ZY, Zhang ZG, Li WB, Zhou XF.

Urol Int. 2014;92(2):202-8. doi: 10.1159/000355175. Epub 2014 Jan 23.

PMID:
24458144
5.

Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms.

Kobayashi H, Yoshiyama M, Zakoji H, Takeda M, Araki I.

BJU Int. 2009 Dec;104(11):1746-51. doi: 10.1111/j.1464-410X.2009.08658.x. Epub 2009 Jun 2.

8.

A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.

Bosch PC.

J Urol. 2014 Jan;191(1):77-82. doi: 10.1016/j.juro.2013.06.038. Epub 2013 Jun 20.

PMID:
23792149
9.

Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A.

Pinto R, Lopes T, Costa D, Barros S, Silva J, Silva C, Cruz C, Dinis P, Cruz F.

Urology. 2014 May;83(5):1030-4. doi: 10.1016/j.urology.2014.01.018.

PMID:
24767520
10.

Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.

Liu HT, Tyagi P, Chancellor MB, Kuo HC.

BJU Int. 2009 Nov;104(10):1476-81. doi: 10.1111/j.1464-410X.2009.08675.x. Epub 2009 Jun 12.

11.

Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C.

Logadottir Y, Delbro D, Fall M, Gjertsson I, Jirholt P, Lindholm C, Peeker R.

J Urol. 2014 Nov;192(5):1564-8. doi: 10.1016/j.juro.2014.04.099. Epub 2014 May 9.

PMID:
24813342
12.

Correlation of gene expression with bladder capacity in interstitial cystitis/bladder pain syndrome.

Colaco M, Koslov DS, Keys T, Evans RJ, Badlani GH, Andersson KE, Walker SJ.

J Urol. 2014 Oct;192(4):1123-9. doi: 10.1016/j.juro.2014.05.047. Epub 2014 May 17.

PMID:
24840534
13.

Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.

Logadottir Y, Delbro D, Lindholm C, Fall M, Peeker R.

Int J Urol. 2014 Apr;21 Suppl 1:75-8. doi: 10.1111/iju.12370.

14.

Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity.

Lokeshwar VB, Selzer MG, Unwala DJ, Estrella V, Gomez MF, Golshani R, Kester RR, Klumpp DJ, Gousse AE.

J Urol. 2006 Sep;176(3):1001-7.

PMID:
16890679
15.

The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder.

Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E.

Neurourol Urodyn. 2007;26(3):433-8; discussion 439; discussion 451-3.

PMID:
17016800
16.

[Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis].

Xu L, Zhang P, Zhang N, Yang Y, Wu ZJ, Zhang CH, Zhang XD.

Zhonghua Yi Xue Za Zhi. 2013 Nov 12;93(42):3347-50. Chinese.

PMID:
24418029
17.

Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.

Pinto R, Lopes T, Silva J, Silva C, Dinis P, Cruz F.

J Urol. 2013 Feb;189(2):548-53. doi: 10.1016/j.juro.2012.09.027. Epub 2012 Dec 14.

PMID:
23253961
18.

Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains.

Kunert-Keil C, Bisping F, Krüger J, Brinkmeier H.

BMC Genomics. 2006 Jun 20;7:159.

19.

Non-bladder conditions in female Taiwanese patients with interstitial cystitis/hypersensitive bladder syndrome.

Fan YH, Lin AT, Lu SH, Chuang YC, Chen KK.

Int J Urol. 2014 Aug;21(8):805-9. doi: 10.1111/iju.12456. Epub 2014 Apr 13.

20.

Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis.

Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP.

J Urol. 2008 Aug;180(2):737-41. doi: 10.1016/j.juro.2008.03.184. Epub 2008 Jun 12.

PMID:
18554637

Supplemental Content

Support Center